[Tianshili: notice of approval of Drug Clinical trial] Tianshili announced that it received approval from the State Drug Administration to issue a "notice of approval for Drug Clinical trial" on the basis of further improving the clinical trial program, agreeing to carry out phase Ⅲ clinical trials for the common cold (wind-cold syndrome).